calendar
2,341 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
next 91 dayslessmore
MonWedFri
2,341 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 3.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.07
Items: 7.01, 9.01
Items: 5.02
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 3.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.03, 5.07, 9.01
Items: 2.02, 9.01
Items: 5.02
Items: 4.02
Items: 5.02
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 3.02, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 9.01
Items: 1.01, 2.03, 3.01, 3.03, 9.01
Items: 2.05, 7.01, 9.01
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01